Cytokinetics Inc. (cytk 3.5 07/01/27)
13F holders, Q4 2025 (December 31)2holders
0new positions
0sold out
$1.42avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Cytokinetics Inc. (cytk 3.5 07/01/27) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($4.5M) and Bank of New York Mellon Corp ($285K).
- Company
- Cytokinetics Inc. (cytk 3.5 07/01/27)
- CUSIP
- 23282WAC4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 1,650,000 shares bought and 100,000 shares sold, net +1,550,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Add +110.0% | 3,150,000 | $4.5M |
| Bank of New York Mellon Corp | 0.00% | Reduce -33.3% | 200,000 | $285K |
"% of holder's portfolio" is CYTOKINETICS INC (CYTK 3.5 07/01/27)'s weight in each manager's 13F, not the share of Cytokinetics Inc. (cytk 3.5 07/01/27) the manager owns.